Edition:
United Kingdom

Adamas Pharmaceuticals Inc (ADMS.OQ)

ADMS.OQ on NASDAQ Stock Exchange Global Market

6.83USD
8:09pm BST
Change (% chg)

$0.19 (+2.86%)
Prev Close
$6.64
Open
$6.65
Day's High
$7.11
Day's Low
$6.50
Volume
268,173
Avg. Vol
102,375
52-wk High
$20.63
52-wk Low
$4.21

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

David Mahoney

64 2019 Lead Independent Chairman of the Board

Neil McFarlane

46 2019 Chief Executive Officer, Director

Alfred Merriweather

65 2017 Chief Financial Officer

Christopher Prentiss

44 2017 Chief Accounting Officer

Jennifer Rhodes

49 2016 Chief Compliance Officer, General Counsel, Corporate Secretary, Chief Business Officer